Presenter Information

Azriel Minjarez-AlmeidaFollow

Student Major/Year in School

Biology, third year

Faculty Mentor Information

Stefan Bossmann

Abstract

Azzy Minjarez1, Man Zhang1, Anjana Delpe-Acharige1, Kayla Eschliman1, Olaf Kutsch2, Stefan H. Bossmann1

1: Department of Chemistry, Kansas State University

2: Department of Medicine, University of Alabama at Birmingham

Copper Binding of Heterocyclic Compounds Is Vital For Novel Drugs Against Resistant Gram-positive Bacteria

Multidrug resistant bacteria are capable of developing resistance to a majority of available antibiotics making them an imminent threat. Thus, synthesizing novel drug candidates is vital. The average adult contains 50-80 mg of copper within the body, which assist the immune system. Efflux pumps of bacterial cells are the primary defense mechanism, which recognize and remove copper. Our research focuses on synthesizing heterocyclic compounds that allow copper to bind and go unnoticed by efflux pumps to fight against the bacteria. To synthesize these heterocyclic compounds, we have used substituted pyrazoles and aryl substituted phenyl isothiocyanate compounds. Column chromatography and recrystallization are then completed to obtain purified products. Finally, the products are structurally verified by using Nuclear magnetic resonance spectroscopy, 1H-NMR and 13C-NMR. In 2019, I have synthesized and purified 17 novel compounds, which led to 5 novel designer drugs capable of copper binding.

Creative Commons License

Creative Commons Attribution-Noncommercial 4.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License

Share

COinS
 

Copper Binding of Heterocyclic Compounds Is Vital For Novel Drugs Against Gram-Positive Bacteria

Azzy Minjarez1, Man Zhang1, Anjana Delpe-Acharige1, Kayla Eschliman1, Olaf Kutsch2, Stefan H. Bossmann1

1: Department of Chemistry, Kansas State University

2: Department of Medicine, University of Alabama at Birmingham

Copper Binding of Heterocyclic Compounds Is Vital For Novel Drugs Against Resistant Gram-positive Bacteria

Multidrug resistant bacteria are capable of developing resistance to a majority of available antibiotics making them an imminent threat. Thus, synthesizing novel drug candidates is vital. The average adult contains 50-80 mg of copper within the body, which assist the immune system. Efflux pumps of bacterial cells are the primary defense mechanism, which recognize and remove copper. Our research focuses on synthesizing heterocyclic compounds that allow copper to bind and go unnoticed by efflux pumps to fight against the bacteria. To synthesize these heterocyclic compounds, we have used substituted pyrazoles and aryl substituted phenyl isothiocyanate compounds. Column chromatography and recrystallization are then completed to obtain purified products. Finally, the products are structurally verified by using Nuclear magnetic resonance spectroscopy, 1H-NMR and 13C-NMR. In 2019, I have synthesized and purified 17 novel compounds, which led to 5 novel designer drugs capable of copper binding.